Clinical trial

GISEL:Registry of Breast Cancer Patients Treated With ECT

NCT06683404

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-04-22

PhaseN/A

Study timeline

Study start (unknown)2016-04-22Date precision: day

Registry last updated2024-11-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Cancer Metastaticunresolved

Breast Cancer Recurrentunresolved

Interventions

Electrochemotherapy (ECT)DEVICE

BleomycinDRUG · verified · RxNorm: bleomycin

Sponsors & collaborators

Istituto Oncologico Veneto IRCCSlead sponsor

Mapped research locations

PadovaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06683404 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.